Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
life sciences
national blog main
boston blog main
boston top stories
clinical trials
boston
fda
national top stories
deals
startups
alexion pharmaceuticals
autoimmune disorders
cancer drugs
colorectal cancer
glaxosmithkline
medical device
neuroscience
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
20/20 healthcare partners
3b pharmaceuticals
abeona therapeutics
acute myeloid leukemia
adicet bio
aegerion pharmaceuticals
akcea therapeutics
alkermes
allan kaspar
allosteric
alnylam pharmaceuticals
altria
alzheimer's disease
amgen
amgen ventures
amphivena therapeutics
amryt pharma
What
disease
8
×
medicines
potential
research
control
drug
new
pharma
pharmaceuticals
proteins
according
accusing
add
address
adds
ago
akcea
allosteric
alternative
alzheimer's
alzheimer’s
amyloid
appeared
associated
autoimmune
biotech
bombshell
called
cancer
cancer’s
candidate
carbidopa
cases
caught
causing
centers
cigarettes
clinic
combination
companies
Language
unset
8
×
Current search:
unset
×
biotech
×
disease
×
@extremetech.com
1 year ago
Potential Research Fabrication Bombshell Threatens Amyloid Theory of Alzheimer’s Disease
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
